Pegasus Therapeutics is combining the latest technology in non-surgical aneurysm treatment and coronary artery stenting to design a bioresorbable flow diverter: a medical device that gives the body a chance to heal and then dissolves away completely after the therapeutic timeframe. Our vision is for children with coronary artery aneurysms to live longer, healthier, more productive lives.